TABLE 3.
Symptoms, Hospitalization, ICU Admission, Invasive Ventilation, and Death by Liver Disease and Vaccination Status
| All CLDs, ≥1 Vaccine Dose (n = 21) | All CLDs, Unvaccinated (n = 225) | Cirrhosis, ≥1 Vaccine Dose (n = 19) | Cirrhosis, Unvaccinated (n = 159) | Prior LT, ≥1 Vaccine Dose (n = 19) | Prior LT, Unvaccinated (n = 77) | |
|---|---|---|---|---|---|---|
| GI and/or respiratory symptoms (n, %) | 13 (62%) | 172 (76%) | 12 (63%) | 118 (74%) | 17 (89%) | 68 (88%) |
| Hospitalization (n, %) | 7 (33%) | 162 (72%) | 7 (37%) | 118 (74%) | 6 (32%) | 33 (43%) |
| ICU admission (n, %) | 1 (5%) | 20 (9%) | 1 (5%) | 15 (9%) | 3 (16%)* | 7 (9%) |
| Invasive ventilation (n, %) | 0 (0%) | 12 (5%) | 0 (0%) | 9 (6%) | 3 (16%)* | 9 (12%) |
| Death (n, %) | 0 (0%) | 18 (8%) | 0 (0%) | 15 (9%) | 2 (11%)* | 6 (8%) |
*
All among patients with a single dose within 1‐2 weeks of SARS‐CoV‐2 diagnosis.